newsfilter
← Latest News
ACCESS Newswire·

Sonnet BioTherapeutics Announces Review of Strategic Alternatives

PRINCETON, NJ / ACCESSWIRE / May 22, 2024 / Sonnet BioTherapeutics Holdings, Inc. , a clinical-stage company developing targeted immunotherapeutic drugs,